Home » Topics » Regulatory » Patents

Patents
RSS

Novel treatments for musculoskeletal and connective tissue disorders claimed in recent patents

Feb. 9, 2007

New treatments for gastrointestinal disorders claimed in recent patent literature

Feb. 9, 2007

Recent Corus patent imparts novel therapeutic agents for chronic obstructive pulmonary disease

Feb. 9, 2007

Recent patents cover novel therapeutic agents for cardiovascular disorders

Feb. 8, 2007

Novel treatment options for hematological disorders disclosed in recent AstraZeneca and IRM patents

Feb. 8, 2007

New therapeutic agents for glaucoma disclosed in recent Aerie patent

Feb. 8, 2007

Recent patents impart new therapeutic agents for cancer

Feb. 7, 2007

Recent Isis and Louisiana State University patents report novel diagnostic agents

Feb. 7, 2007

Novel immunomodulatory agents disclosed in recent Kyorin and Novartis patents

Feb. 7, 2007

Virginia Commonwealth University and Nicogen jointly divulge novel antismoking agents

Feb. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.